Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Oncology

  • 1
    News

    INR fails to predict bleeding in patients with cirrhosis

    October 6, 2020

    The investigators hope the study findings reinforce minimizing administration of fresh frozen plasma for inappropriate correction of international normalized ratio, which carries a multitude of adverse effects among cirrhotic patients.

  • News

    COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate

    September 16, 2020

    No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments during the COVID-19 pandemic, although more research is needed and shared decision making is warranted.

  • News

    Infectious COVID-19 can persist in gut for weeks

    September 14, 2020

    “We found active and prolonged SARS-CoV-2 infection in the stool of patients with COVID-19, even after recovery, suggesting that coronavirus could remain in the gut of asymptomatic carriers.”

  • 1
    News

    Performance status, molecular testing key to metastatic cancer prognosis

    August 20, 2020

    “The applicability of clinical trials data to hospitalized patients is generally poor. That’s an important caveat to keep in mind.”

  • News

    Higher death rate seen in cancer patients with nosocomial COVID-19

    July 30, 2020

    All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.

  • 1
    News

    MIS-C is a serious immune-mediated response to COVID-19 infection

    July 28, 2020

    Multisystem inflammatory syndrome in children (MIS-C) is still a moving target because there is much still to learn about it.

  • News

    Preliminary evidence indicates famotidine might improve COVID-19 symptoms

    June 9, 2020

    Apart from two cases of anosmia, symptoms resolved completely within 14 days of starting famotidine.

  • 1
    News

    Patient-focused precautions, testing help blunt pandemic effects on heme-onc unit

    May 26, 2020

    Multiple factors helped keep the anticipated COVID-19 surge manageable at the hematologic oncology service of Levine Cancer Institute.

  • 1
    Opinion

    Summary of the IDSA guidelines on the diagnosis of COVID-19

    May 14, 2020

    Learn about those recommendations that are most relevant to primary care clinicians.

  • News

    Androgens may explain male vulnerability to COVID-19

    May 8, 2020

    Androgen deprivation therapy may be protective against COVID-19, a study suggests.

Previous1 2 3 4 5 … 7Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences